Purchase Order 75F40119P10553
Award Date 8/27/19
Potential Completion Date 10/28/19
Potential Value $112K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Uniformed Services University of the Health Sciences (USUHS), a defense agency, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The $91,259 contract, titled "STEMVISION," is for the delivery of an automated instrument capable of counting different types of mouse hematopoietic progenitor cells from a single culture plate. This contract was not set aside for small...
- This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a Canadian biotechnology company, to purchase a RoboSep-S automated cell separation system with a 5-year warranty and maintenance service. The contract, valued at $94,612.00, does not have a small business set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian parent...
- <p>The Food and Drug Administration issued a purchase order to Stemcell Technologies Inc. valued at $14,171.00 on August 1, 2023 for preventive maintenance and repair service for a Stemcell Technologies StemVision Instrument (serial number SV-00212). Work is performed in Silver Spring, Maryland. The order was firm fixed price with an ultimate completion date of July 31, 2024. No set-aside was applied.</p>
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- The Food and Drug Administration issued a purchase order to Stemcell Technologies Inc., a total small business set-aside, for $24,664 in semi-solid culture media with an award date of August 15, 2023 and ultimate completion date of August 14, 2024. Performance is located in Silver Spring, Maryland. The order procures specialized biological research materials and cell culture media supporting federal health agency research operations. Stemcell Technologies Inc. is a foreign-owned subsidiary of...